Report cover image

Global Induced Pluripotent Stem Cells (iPSCs) Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Feb 09, 2025
Length 189 Pages
SKU # APRC19875130

Description

Summary

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.

According to APO Research, The global Induced Pluripotent Stem Cells (iPSCs) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Induced Pluripotent Stem Cells (iPSCs) include Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology and ReproCELL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Induced Pluripotent Stem Cells (iPSCs), market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Induced Pluripotent Stem Cells (iPSCs), also provides the revenue of main regions and countries. Of the upcoming market potential for Induced Pluripotent Stem Cells (iPSCs), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Induced Pluripotent Stem Cells (iPSCs) revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Induced Pluripotent Stem Cells (iPSCs) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Induced Pluripotent Stem Cells (iPSCs) revenue, projected growth trends, production technology, application and end-user industry.


Induced Pluripotent Stem Cells (iPSCs) Segment by Company

Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL

Induced Pluripotent Stem Cells (iPSCs) Segment by Type

Human iPSCs
Mouse iPSCs

Induced Pluripotent Stem Cells (iPSCs) Segment by Application

Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others

Induced Pluripotent Stem Cells (iPSCs) Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Induced Pluripotent Stem Cells (iPSCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Induced Pluripotent Stem Cells (iPSCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Induced Pluripotent Stem Cells (iPSCs).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Induced Pluripotent Stem Cells (iPSCs) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Induced Pluripotent Stem Cells (iPSCs) industry.
Chapter 3: Detailed analysis of Induced Pluripotent Stem Cells (iPSCs) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Induced Pluripotent Stem Cells (iPSCs)revenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

189 Pages
1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Human iPSCs
1.2.3 Mouse iPSCs
1.3 Market Analysis by Application
1.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.3.2 Academic Research
1.3.3 Drug Development and Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.3.6 Others
1.4 Global Market Growth Prospects
1.5 Global Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Region
1.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2020 VS 2024 VS 2031
1.5.2 Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2020-2025)
1.5.3 Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2026-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Induced Pluripotent Stem Cells (iPSCs) Market Dynamics
2.1 Induced Pluripotent Stem Cells (iPSCs) Industry Trends
2.2 Induced Pluripotent Stem Cells (iPSCs) Industry Drivers
2.3 Induced Pluripotent Stem Cells (iPSCs) Industry Opportunities and Challenges
2.4 Induced Pluripotent Stem Cells (iPSCs) Industry Restraints
3 Competitive Landscape by Company
3.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Company (2020-2025)
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Players Revenue Ranking, 2023 VS 2024 VS 2025
3.3 Global Induced Pluripotent Stem Cells (iPSCs) Key Company Head office and Area Served
3.4 Global Induced Pluripotent Stem Cells (iPSCs) Company, Product Type & Application
3.5 Global Induced Pluripotent Stem Cells (iPSCs) Company Establishment Date
3.6 Market Competitive Analysis
3.6.1 Global Induced Pluripotent Stem Cells (iPSCs) Market CR5 and HHI
3.6.2 Global Top 5 and 10 Induced Pluripotent Stem Cells (iPSCs) Players Market Share by Revenue in 2024
3.6.3 2024 Induced Pluripotent Stem Cells (iPSCs) Tier 1, Tier 2, and Tier 3
4 Induced Pluripotent Stem Cells (iPSCs) Market by Type
4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2020 VS 2024 VS 2031)
4.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2020-2031)
4.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Type (2020-2031)
5 Induced Pluripotent Stem Cells (iPSCs) Market by Application
5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020 VS 2024 VS 2031)
5.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2031)
5.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Application (2020-2031)
6 Company Profiles
6.1 Fujifilm Holding Corporation (CDI)
6.1.1 Fujifilm Holding Corporation (CDI) Comapny Information
6.1.2 Fujifilm Holding Corporation (CDI) Business Overview
6.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2020-2025)
6.1.4 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.1.5 Fujifilm Holding Corporation (CDI) Recent Developments
6.2 Ncardia
6.2.1 Ncardia Comapny Information
6.2.2 Ncardia Business Overview
6.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2020-2025)
6.2.4 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.2.5 Ncardia Recent Developments
6.3 Sumitomo Dainippon Pharma
6.3.1 Sumitomo Dainippon Pharma Comapny Information
6.3.2 Sumitomo Dainippon Pharma Business Overview
6.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2020-2025)
6.3.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.3.5 Sumitomo Dainippon Pharma Recent Developments
6.4 Astellas Pharma Inc
6.4.1 Astellas Pharma Inc Comapny Information
6.4.2 Astellas Pharma Inc Business Overview
6.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2020-2025)
6.4.4 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.4.5 Astellas Pharma Inc Recent Developments
6.5 Fate Therapeutics, Inc
6.5.1 Fate Therapeutics, Inc Comapny Information
6.5.2 Fate Therapeutics, Inc Business Overview
6.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2020-2025)
6.5.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.5.5 Fate Therapeutics, Inc Recent Developments
6.6 Pluricell Biotech
6.6.1 Pluricell Biotech Comapny Information
6.6.2 Pluricell Biotech Business Overview
6.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2020-2025)
6.6.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.6.5 Pluricell Biotech Recent Developments
6.7 Cell Inspire Biotechnology
6.7.1 Cell Inspire Biotechnology Comapny Information
6.7.2 Cell Inspire Biotechnology Business Overview
6.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2020-2025)
6.7.4 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.7.5 Cell Inspire Biotechnology Recent Developments
6.8 ReproCELL
6.8.1 ReproCELL Comapny Information
6.8.2 ReproCELL Business Overview
6.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2020-2025)
6.8.4 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
6.8.5 ReproCELL Recent Developments
7 North America
7.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031)
7.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
7.2.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2020-2025)
7.2.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2026-2031)
7.2.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2020-2031)
7.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
7.3.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025)
7.3.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2026-2031)
7.3.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2020-2031)
7.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
7.4.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020 VS 2024 VS 2031)
7.4.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
7.4.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2026-2031)
7.4.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2020-2031)
7.4.5 United States
7.4.6 Canada
7.4.7 Mexico
8 Europe
8.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031)
8.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
8.2.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2020-2025)
8.2.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2026-2031)
8.2.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2020-2031)
8.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
8.3.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025)
8.3.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2026-2031)
8.3.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2020-2031)
8.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
8.4.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020 VS 2024 VS 2031)
8.4.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
8.4.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2026-2031)
8.4.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2020-2031)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031)
9.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
9.2.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2020-2025)
9.2.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2026-2031)
9.2.3 China Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2020-2031)
9.3 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
9.3.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025)
9.3.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2026-2031)
9.3.3 China Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2020-2031)
10 Asia (Excluding China)
10.1 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031)
10.2 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
10.2.1 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2020-2025)
10.2.2 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2026-2031)
10.2.3 Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2020-2031)
10.3 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
10.3.1 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025)
10.3.2 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2026-2031)
10.3.3 Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2020-2031)
10.4 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
10.4.1 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020 VS 2024 VS 2031)
10.4.2 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
10.4.3 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2026-2031)
10.4.4 Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2020-2031)
10.4.5 Japan
10.4.6 South Korea
10.4.7 Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 South America, Middle East & Africa
11.1 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031)
11.2 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
11.2.1 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2020-2025)
11.2.2 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2026-2031)
11.2.3 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2020-2031)
11.3 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
11.3.1 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025)
11.3.2 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2026-2031)
11.3.3 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2020-2031)
11.4 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
11.4.1 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020 VS 2024 VS 2031)
11.4.2 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
11.4.3 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2026-2031)
11.4.4 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2020-2031)
11.4.5 Brazil
11.4.6 South Africa
11.4.7 Saudi Arabia
11.4.8 Turkey
11.4.9 Argentina
11.4.9 UAE
11.4.9 Egypt
11.4.9 Chile
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.